X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (79) 79
hygiene (79) 79
medical or veterinary science (79) 79
preparations for medical, dental, or toilet purposes (79) 79
specific therapeutic activity of chemical compounds ormedicinal preparations (79) 79
chemistry (77) 77
metallurgy (77) 77
heterocyclic compounds (70) 70
organic chemistry (70) 70
humans (15) 15
oncology (13) 13
female (12) 12
middle aged (10) 10
aged (9) 9
adult (8) 8
male (8) 8
beer (7) 7
biochemistry (7) 7
compositions or test papers therefor (7) 7
condition-responsive control in microbiological orenzymological processes (7) 7
enzymology (7) 7
index medicus (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
measuring (7) 7
measuring or testing processes involving enzymes, nucleicacids or microorganisms (7) 7
microbiology (7) 7
mutation or genetic engineering (7) 7
physics (7) 7
processes of preparing such compositions (7) 7
spirits (7) 7
testing (7) 7
treatment outcome (7) 7
vinegar (7) 7
wine (7) 7
cancer (6) 6
neoplasms - drug therapy (5) 5
research (5) 5
breast neoplasms - drug therapy (4) 4
care and treatment (4) 4
clinical trials (4) 4
hematology, oncology and palliative medicine (4) 4
oncology, experimental (4) 4
survival analysis (4) 4
administration, oral (3) 3
analysis (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - pathology (3) 3
drug dosages (3) 3
guanidines - administration & dosage (3) 3
guanidines - pharmacokinetics (3) 3
guanidines - therapeutic use (3) 3
maximum tolerated dose (3) 3
postmenopause (3) 3
pyrroles - administration & dosage (3) 3
pyrroles - pharmacokinetics (3) 3
pyrroles - therapeutic use (3) 3
tumors (3) 3
aged, 80 and over (2) 2
aminoglutethimide (2) 2
anastrozole (2) 2
androstadienes - administration & dosage (2) 2
androstadienes - therapeutic use (2) 2
antibody (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - toxicity (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
apoptosis (2) 2
area under curve (2) 2
aromatase inhibitors - administration & dosage (2) 2
binding (2) 2
breast cancer (2) 2
breast neoplasms - enzymology (2) 2
breast neoplasms - genetics (2) 2
brostallicin (2) 2
cancer therapies (2) 2
carcinoma (2) 2
chemotherapy (2) 2
clear cell-type renal cell carcinoma (2) 2
clinical trials, phase i as topic (2) 2
cyclin-dependent kinase 4 - antagonists & inhibitors (2) 2
cyclin-dependent kinase 4 - metabolism (2) 2
cyclin-dependent kinase 6 - antagonists & inhibitors (2) 2
cyclin-dependent kinase 6 - metabolism (2) 2
designs (2) 2
disease progression (2) 2
dosage and administration (2) 2
dose-response relationship, drug (2) 2
drug synergism (2) 2
drug therapy (2) 2
europe (2) 2
infusions, intravenous (2) 2
melanoma - secondary (2) 2
metastasis (2) 2
models, chemical (2) 2
molecular targeted therapy (2) 2
neoplasm metastasis (2) 2
pd-l1 protein (2) 2
phosphorylation (2) 2
postmenopausal women (2) 2
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (78) 78
French (19) 19
German (13) 13
Spanish (6) 6
Portuguese (4) 4
Norwegian (3) 3
Polish (3) 3
Chinese (2) 2
Czech (2) 2
Estonian (2) 2
Hungarian (2) 2
Danish (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 451 - 460
The combination of an immune checkpoint inhibitor and a VEGF pathway inhibitor to treat patients with advanced renal-cell carcinoma might increase the clinical... 
TUMOR | ANTIBODY | TARGETED THERAPIES | ATEZOLIZUMAB | ONCOLOGY | SAFETY | Care and treatment | Carcinoma | Analysis | Cancer
Journal Article
Breast Cancer Research, ISSN 1465-5411, 10/2009, Volume 11, Issue 5, pp. R77 - R77
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2000, Volume 18, Issue 7, pp. 1399 - 1411
Purpose: This phase ill, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator... 
ONCOLOGY | HORMONAL TREATMENT | STEROIDAL AROMATASE INHIBITOR | AMINOGLUTETHIMIDE | ENDOCRINE | ANASTROZOLE
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, Issue 15, pp. 2256 - 2264
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2006, Volume 43, Issue 2, pp. 308 - 315
Journal Article